Scorpion details early data on targeted breast cancer drug as it seeks to challenge Novartis, Roche
Read More
Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver transformational therapies for larger populations of patients with cancer
Cancer has always been an elusive foe, capable of evolving to evade our attempts at eradication. From genetic mutations and chromosomal instabilities to changes in key enzymes and proteins, the drivers that tumor cells rely on to survive can be exploited for therapeutic benefit – an insight that led to the first successful precision oncology therapies more than 20 years ago.
We’ve come a long way from the early days of cancer therapies. Yet, the full promise of personalized medicine has not yet been realized, as only a small number of these drivers have been successfully targeted and treated with precision therapies.
Currently, about 14% of all patients with cancer are eligible for existing precision oncology therapies and only 7% realize clinical benefits.1
We aim to change that.
Aiming to deliver a fast, precise and lethal strike at cancer’s unique drivers
Before we launch a program against a new, high-value target, we always ask ourselves:
Why our work matters
We are developing drugs specifically designed to interact with validated cancer targets with greater selectivity and optimized pharmaceutical properties to improve their safety and efficacy.
Meet our
leadership team
Our world-class team is comprised of experts in cancer biology, medicinal chemistry, next-generation chemical proteomics, computational chemistry and molecular biophysics, machine learning, and drug development. Together, they have architected a new and innovative approach to target and drug discovery.
News
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Growing a thriving culture
The work environment we have created is as important to us as our science. We are looking for team members who share our cultural commitments.